Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy

被引:11
作者
Alves, Francesca M. [1 ,3 ]
Kysenius, Kai [2 ]
Caldow, Marissa K. [1 ]
Hardee, Justin P. [1 ]
Chung, Jin D. [1 ]
Trieu, Jennifer [1 ]
Hare, Dominic J. [4 ]
Crouch, Peter J. [2 ]
Ayton, Scott [3 ]
Bush, Ashley, I [3 ]
Lynch, Gordon S. [1 ]
Koopman, Rene [1 ]
机构
[1] Univ Melbourne, Ctr Muscle Res, Dept Anat & Physiol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Dept Biochem & Pharmacol, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne Dementia Res Ctr, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia
[4] Monash Univ, Monash eRes Ctr, Clayton, Vic, Australia
关键词
Muscular dystrophy; Muscle metabolism; Iron; Oxidative stress; OXIDATIVE DAMAGE; MUSCLE; DEFICIENCY; MICE; DEFERIPRONE; MYOGLOBIN; ABLATION; CALCIUM;
D O I
10.1002/jcsm.12950
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Oxidative stress is implicated in the pathophysiology of Duchenne muscular dystrophy (DMD, caused by mutations in the dystrophin gene), which is the most common and severe of the muscular dystrophies. To our knowledge, the distribution of iron, an important modulator of oxidative stress, has not been assessed in DMD. We tested the hypotheses that iron accumulation occurs in mouse models of DMD and that modulation of iron through the diet or chelation could modify disease severity. Methods We assessed iron distribution and total elemental iron using LA-ICP-MS on skeletal muscle cross-sections of 8-week-old Bl10 control mice and dystrophic mdx mice (with moderate dystrophy) and dystrophin/utrophin-null mice (dko, with severe dystrophy). In addition, mdx mice (4 weeks) were treated with either an iron chelator (deferiprone 150 mg/kg/day) or iron-enriched feed (containing 1% added iron as carbonyl iron). Immunoblotting was used to determine the abundance of iron- and mitochondria-related proteins. (Immuno)histochemical and mRNA assessments of fibrosis and inflammation were also performed. Results We observed a significant increase in total elemental iron in hindlimb muscles of dko mice (+50%, P < 0.05) and in the diaphragm of mdx mice (+80%, P < 0.05), with both tissues exhibiting severe pathology. Iron dyshomeostasis was further evidenced by an increase in the storage protein ferritin (dko: +39%, P < 0.05) and ferroportin compared with Bl10 control mice (mdx: +152% and dko: +175%, P < 0.05). Despite having features of iron overload, dystrophic muscles had lower protein expression of ALAS-1, the rate-limiting enzyme for haem synthesis (dko -44%, P < 0.05), and the haem-containing protein myoglobin (dko -54%, P < 0.05). Deferiprone treatment tended to decrease muscle iron levels in mdx mice (-30%, P < 0.1), which was associated with lower oxidative stress and fibrosis, but suppressed haem-containing proteins and mitochondrial content. Increasing iron via dietary intervention elevated total muscle iron (+25%, P < 0.05) but did not aggravate the pathology. Conclusions Muscles from dystrophic mice have increased iron levels and dysregulated iron-related proteins that are associated with dystrophic pathology. Muscle iron levels were manipulated by iron chelation and iron enriched feed. Iron chelation reduced fibrosis and reactive oxygen species (ROS) but also suppressed haem-containing proteins and mitochondrial activity. Conversely, iron supplementation increased ferritin and haem-containing proteins but did not alter ROS, fibrosis, or mitochondrial activity. Further studies are required to investigate the contribution of impaired ferritin breakdown in the dysregulation of iron homeostasis in DMD.
引用
收藏
页码:1541 / 1553
页数:13
相关论文
共 44 条
[21]  
Klingler Werner, 2012, Acta Myol, V31, P184
[22]  
Kühn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]
[23]   A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samples [J].
Kysenius, Kai ;
Paul, Bence ;
Hilton, James B. ;
Liddell, Jeffrey R. ;
Hare, Dominic J. ;
Crouch, Peter J. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2019, 411 (03) :603-616
[24]   Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy [J].
McGreevy, Joe W. ;
Hakim, Chady H. ;
McIntosh, Mark A. ;
Duan, Dongsheng .
DISEASE MODELS & MECHANISMS, 2015, 8 (03) :195-213
[25]   LIPID-PEROXIDATION AND SUPEROXIDE-DISMUTASE ACTIVITY IN MUSCLE AND ERYTHROCYTES IN DUCHENNE MUSCULAR-DYSTROPHY [J].
MECHLER, F ;
IMRE, S ;
DIOSZEGHY, P .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1984, 63 (03) :279-283
[26]   Iron deficiency, fatigue and muscle strength and function in older hospitalized patients [J].
Neidlein, Sophia ;
Wirth, Rainer ;
Pourhassan, Maryam .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (03) :456-463
[27]   Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major [J].
Olivieri, NF ;
Brittenham, GM ;
McLaren, CE ;
Templeton, DM ;
Cameron, RG ;
McClelland, RA ;
Burt, AD ;
Fleming, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07) :417-423
[28]   GLUTATHIONE PEROXIDASE, GLUTATHIONE REDUCTASE, AND THIOBARBITURIC ACID-REACTIVE PRODUCTS IN MUSCLES OF CHICKENS AND MICE WITH GENETIC MUSCULAR-DYSTROPHY [J].
OMAYE, ST ;
TAPPEL, AL .
LIFE SCIENCES, 1974, 15 (01) :137-145
[29]   REDUCED DEFORMABILITY OF ERYTHROCYTE-MEMBRANES FROM PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY [J].
PERCY, AK ;
MILLER, ME .
NATURE, 1975, 258 (5531) :147-148
[30]   Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases [J].
Phaniendra A. ;
Jestadi D.B. ;
Periyasamy L. .
Indian Journal of Clinical Biochemistry, 2015, 30 (1) :11-26